It has been found that blocking the interaction between ARMC12 and RBBP4 by cell‐penetrating inhibitory peptides can activate the expression of downstream genes and inhibit the tumorigenesis and invasiveness of neuroblastoma cells.40 The gene discussed is ARMC12; the disease is neuroblastoma.